Instil Bio, Inc. (TIL)

Instil Bio Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	5.54	6.64	8.81	9.2	43.72	37.59
Short-Term Investments	64.14	69.49	104.51	141.16	217.2	416.51
Trading Asset Securities	-	-	-	1.06	2.2	-
Cash & Short-Term Investments	69.68	76.13	113.32	151.41	263.12	454.1
Cash Growth	-24.12%	-32.82%	-25.16%	-42.46%	-42.06%	87.87%
Other Receivables	-	0.85	2.62	-	-	-
Receivables	-	0.85	2.62	-	-	-
Prepaid Expenses	1.67	2.04	5.74	7.85	6.26	9.92
Restricted Cash	0.25	0.17	1.83	1.5	-	-
Other Current Assets	-	112.24	0.96	-	-	-
Total Current Assets	71.61	191.43	124.47	160.76	269.38	464.02
Property, Plant & Equipment	113.93	0.36	130.34	141.07	209.34	122
Long-Term Investments	-	-	-	23.16	-	-
Goodwill	-	-	-	-	-	5.72
Other Intangible Assets	-	-	-	-	-	10.1
Other Long-Term Assets	12.18	11.73	8.76	0.64	3.41	8.14
Total Assets	197.71	203.52	263.57	325.63	482.13	609.98

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	0.8	0.78	0.66	1.21	2.36	5.57
Accrued Expenses	2.51	3.54	3.48	4.27	9.3	21.45
Current Portion of Leases	-	0.37	1.68	1.75	2.38	-
Current Income Taxes Payable	-	-	-	-	-	0.52
Other Current Liabilities	-	0.16	2.07	3.33	18.75	13.81
Total Current Liabilities	3.31	4.84	7.9	10.56	32.79	41.36
Long-Term Debt	85.19	84.81	84.19	81.43	72.35	-
Long-Term Leases	1.84	-	1.02	2.88	5.17	-
Long-Term Deferred Tax Liabilities	-	-	-	-	-	2.43
Other Long-Term Liabilities	-	0.01	1.03	4.94	8.21	11
Total Liabilities	90.33	89.66	94.13	99.8	118.52	54.78

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Additional Paid-In Capital	842.96	840.94	824.78	807.16	788.99	757
Retained Earnings	-734.99	-726.49	-655.12	-580.98	-424.89	-201.72
Comprehensive Income & Other	-0.59	-0.58	-0.23	-0.35	-0.49	-0.09
Total Common Equity	107.38	113.87	169.44	225.83	363.61	555.2
Shareholders' Equity	107.38	113.87	169.44	225.83	363.61	555.2
Total Liabilities & Equity	197.71	203.52	263.57	325.63	482.13	609.98

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	87.03	85.18	86.89	86.05	79.9	-
Net Cash (Debt)	-17.35	-9.05	26.43	65.36	183.22	454.1
Net Cash Growth	-	-	-59.56%	-64.33%	-59.65%	87.87%
Net Cash Per Share	-2.56	-1.36	4.06	10.05	28.29	85.68
Filing Date Shares Outstanding	6.78	6.78	6.53	6.5	6.5	6.46
Total Common Shares Outstanding	6.78	6.78	6.53	6.5	6.5	6.45
Working Capital	68.3	186.59	116.57	150.2	236.59	422.66
Book Value Per Share	15.83	16.79	25.96	34.72	55.91	86.06
Tangible Book Value	107.38	113.87	169.44	225.83	363.61	539.37
Tangible Book Value Per Share	15.83	16.79	25.96	34.72	55.91	83.61
Land	-	-	31.24	31.24	31.24	31.24
Buildings	-	-	102.43	102.43	32.78	6.03
Machinery	-	0.51	0.51	11.14	32.89	17.98
Construction In Progress	-	-	-	-	104.12	67.88
Leasehold Improvements	-	-	-	1.42	4.34	1.84

SEC Filings: 10-K · 10-Q

Data Source: S&P Global Market Intelligence Last updated: May 15, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 19, 2026

Data Sources Report a data error